» Articles » PMID: 30825182

Computer Aided Quantification of Intratumoral Stroma Yields an Independent Prognosticator in Rectal Cancer

Overview
Publisher Springer
Date 2019 Mar 3
PMID 30825182
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Tumor-stroma ratio (TSR) serves as an independent prognostic factor in colorectal cancer and other solid malignancies. The recent introduction of digital pathology in routine tissue diagnostics holds opportunities for automated TSR analysis. We investigated the potential of computer-aided quantification of intratumoral stroma in rectal cancer whole-slide images.

Methods: Histological slides from 129 rectal adenocarcinoma patients were analyzed by two experts who selected a suitable stroma hot-spot and visually assessed TSR. A semi-automatic method based on deep learning was trained to segment all relevant tissue types in rectal cancer histology and subsequently applied to the hot-spots provided by the experts. Patients were assigned to a 'stroma-high' or 'stroma-low' group by both TSR methods (visual and automated). This allowed for prognostic comparison between the two methods in terms of disease-specific and disease-free survival times.

Results: With stroma-low as baseline, automated TSR was found to be prognostic independent of age, gender, pT-stage, lymph node status, tumor grade, and whether adjuvant therapy was given, both for disease-specific survival (hazard ratio = 2.48 (95% confidence interval 1.29-4.78)) and for disease-free survival (hazard ratio = 2.05 (95% confidence interval 1.11-3.78)). Visually assessed TSR did not serve as an independent prognostic factor in multivariate analysis.

Conclusions: This work shows that TSR is an independent prognosticator in rectal cancer when assessed automatically in user-provided stroma hot-spots. The deep learning-based technology presented here may be a significant aid to pathologists in routine diagnostics.

Citing Articles

Tumor‑stroma ratio as a clinical prognostic factor in colorectal carcinoma: A meta‑analysis of 7,934 patients.

Shang A, Yu P, Li L, He G, Xu J Oncol Lett. 2025; 29(4):190.

PMID: 40041409 PMC: 11877013. DOI: 10.3892/ol.2025.14936.


AI-based tumor-stroma ratio quantification algorithm: comprehensive evaluation of prognostic role in primary colorectal cancer.

Carvalho R, Zander T, Barroso V, Bekisoglu A, Zerbe N, Klein S Virchows Arch. 2025; .

PMID: 39948241 DOI: 10.1007/s00428-025-04048-y.


Deep learning application in prediction of cancer molecular alterations based on pathological images: a bibliographic analysis via CiteSpace.

Xiaojian Y, Zhanbo Q, Jian C, Zefeng W, Jian L, Jin L J Cancer Res Clin Oncol. 2024; 150(10):467.

PMID: 39422817 PMC: 11489169. DOI: 10.1007/s00432-024-05992-z.


A predictive model and rapid multi-dynamic algorithm developed based on tumor-stroma percentage in gastric cancer: a retrospective, observational study.

Xu Y, Yang Y, Cheng F, Luo Z, Zhang Y, Zhang P Gastroenterol Rep (Oxf). 2024; 12:goae083.

PMID: 39399262 PMC: 11470210. DOI: 10.1093/gastro/goae083.


The Glasgow Microenvironment Score: an exemplar of contemporary biomarker evolution in colorectal cancer.

Knight K, Bigley C, Pennel K, Hay J, Maka N, McMillan D J Pathol Clin Res. 2024; 10(4):e12385.

PMID: 38853386 PMC: 11163018. DOI: 10.1002/2056-4538.12385.


References
1.
Mesker W, Junggeburt J, Szuhai K, Heer P, Morreau H, Tanke H . The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol. 2007; 29(5):387-98. PMC: 4617992. DOI: 10.1155/2007/175276. View

2.
Gray R, Barnwell J, McConkey C, Hills R, Williams N, Kerr D . Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007; 370(9604):2020-9. DOI: 10.1016/S0140-6736(07)61866-2. View

3.
West N, Dattani M, McShane P, Hutchins G, Grabsch J, Mueller W . The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer. 2010; 102(10):1519-23. PMC: 2869173. DOI: 10.1038/sj.bjc.6605674. View

4.
Moorman A, Vink R, Heijmans H, van der Palen J, Kouwenhoven E . The prognostic value of tumour-stroma ratio in triple-negative breast cancer. Eur J Surg Oncol. 2012; 38(4):307-13. DOI: 10.1016/j.ejso.2012.01.002. View

5.
Linder N, Konsti J, Turkki R, Rahtu E, Lundin M, Nordling S . Identification of tumor epithelium and stroma in tissue microarrays using texture analysis. Diagn Pathol. 2012; 7:22. PMC: 3315400. DOI: 10.1186/1746-1596-7-22. View